These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2650653)

  • 1. Solid and hematologic malignancies in 60 patients with systemic mast cell disease.
    Travis WD; Li CY; Bergstralh EJ
    Arch Pathol Lab Med; 1989 Apr; 113(4):365-8. PubMed ID: 2650653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematologic aspects of mastocytosis: II: management of hematologic disorders in association with systemic mast cell disease.
    Parker RI
    J Invest Dermatol; 1991 Mar; 96(3):52S-53S; discussion 53S-54S. PubMed ID: 2002265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Systemic mastocytosis and secondary acute myeloid leukemia].
    Galán Alvarez P; Ibáñez García J; Funes Vera C; López García-Carreño MD; Alix Trueba A; Pérez Guillermo M; Alberola C
    An Med Interna; 1999 Sep; 16(9):466-8. PubMed ID: 10609361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Splenectomy in the management of systemic mast cell disease.
    Friedman B; Darling G; Norton J; Hamby L; Metcalfe D
    Surgery; 1990 Jan; 107(1):94-100. PubMed ID: 2404352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic mastocytosis with associated clonal hematological non-mast-cell lineage disease: analysis of clinicopathologic features and activating c-kit mutations.
    Pullarkat VA; Bueso-Ramos C; Lai R; Kroft S; Wilson CS; Pullarkat ST; Bu X; Thein M; Lee M; Brynes RK
    Am J Hematol; 2003 May; 73(1):12-7. PubMed ID: 12701114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hematologic manifestations of systemic mast cell disease: a prospective study of laboratory and morphologic features and their relation to prognosis.
    Lawrence JB; Friedman BS; Travis WD; Chinchilli VM; Metcalfe DD; Gralnick HR
    Am J Med; 1991 Dec; 91(6):612-24. PubMed ID: 1750431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycosis fungoides associated with B-cell malignancies.
    Barzilai A; Trau H; David M; Feinmesser M; Bergman R; Shpiro D; Schiby G; Rosenblatt K; Or R; Hodak E
    Br J Dermatol; 2006 Aug; 155(2):379-86. PubMed ID: 16882178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow mast cell morphologic features and hematopoietic dyspoiesis in systemic mast cell disease.
    Stevens EC; Rosenthal NS
    Am J Clin Pathol; 2001 Aug; 116(2):177-82. PubMed ID: 11488063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic mast cell disease. Analysis of 58 cases and literature review.
    Travis WD; Li CY; Bergstralh EJ; Yam LT; Swee RG
    Medicine (Baltimore); 1988 Nov; 67(6):345-68. PubMed ID: 3054417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relative risk of second nongerminal malignancies in patients with extragonadal germ cell tumors.
    Hartmann JT; Nichols CR; Droz JP; Horwich A; Gerl A; Fossa SD; Beyer J; Pont J; Einhorn L; Kanz L; Bokemeyer C
    Cancer; 2000 Jun; 88(11):2629-35. PubMed ID: 10861442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic mastocytosis in association with chronic lymphocytic leukemia: a rare diagnosis.
    Ault P; Lynn A; Tam CS; Medeiros LJ; Keating MJ
    Leuk Res; 2007 Dec; 31(12):1755-8. PubMed ID: 17521719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Second cancers in hematologic malignancies (epidemiologic observations from a 20-year period)].
    Jakó J; Szerafin L; Nagy P
    Orv Hetil; 2005 Mar; 146(10):461-9. PubMed ID: 15835344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Association of multiple myeloma and solid neoplasms: analysis of 13 cases].
    Todolí Parra JA; Campo López C; Segura Huerta A; Alonso Estellés R; Saro Pérez E; Torrego Giménez A; Santaballa Bertrán A; Pastor Borgoñón M; Calabuig Alborch JR
    Rev Clin Esp; 1999 Nov; 199(11):725-8. PubMed ID: 10638237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic mast cell disease (mastocytosis). General aspects and histopathological diagnosis.
    Horny HP; Ruck P; Kröber S; Kaiserling E
    Histol Histopathol; 1997 Oct; 12(4):1081-9. PubMed ID: 9302569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of systemic mast cell disease with associated hematologic disorders.
    Travis WD; Li CY; Yam LT; Bergstralh EJ; Swee RG
    Cancer; 1988 Sep; 62(5):965-72. PubMed ID: 3409177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Systemic mast cell disease associated with cutaneous xanthomas and markedly elevated serum IgE].
    Hino N; Yamabe T; Ono T; Sasaki N; Nanba K
    Rinsho Ketsueki; 1990 Sep; 31(9):1478-82. PubMed ID: 2246820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I/II study of the mammalian target of rapamycin inhibitor everolimus (RAD001) in patients with relapsed or refractory hematologic malignancies.
    Yee KW; Zeng Z; Konopleva M; Verstovsek S; Ravandi F; Ferrajoli A; Thomas D; Wierda W; Apostolidou E; Albitar M; O'Brien S; Andreeff M; Giles FJ
    Clin Cancer Res; 2006 Sep; 12(17):5165-73. PubMed ID: 16951235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematologic malignancies in patients with cryoglobulinemia: association with autoimmune and chronic viral diseases.
    Trejo O; Ramos-Casals M; López-Guillermo A; García-Carrasco M; Yagüe J; Cervera R; Font J; Ingelmo M
    Semin Arthritis Rheum; 2003 Aug; 33(1):19-28. PubMed ID: 12920693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic mast cell disease associated with the hypereosinophilic syndrome.
    McElroy EA; Phyliky RL; Li CY
    Mayo Clin Proc; 1998 Jan; 73(1):47-50. PubMed ID: 9443678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An association between renal cell carcinoma and lymphoid malignancies. A case series of eight patients.
    Nishikubo CY; Kunkel LA; Figlin R; Belldegrun A; Rosen P; Elashoff R; Wang H; Territo MC
    Cancer; 1996 Dec; 78(11):2421-6. PubMed ID: 8941014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.